• Latest Posts

CatalYm shows importance of GDF-15 in tumor immunotherapy resistance

Endometrial cancer drug receives breakthrough therapy designation in China 

Moleculin issues acute myeloid leukemia drug data

TME Pharma provides positive glioblastoma trial results

Calliditas reveals ‘encouraging results’ from head and neck cancer trial 

ADC Therapeutics pauses clinical trial following patient deaths

ADVERTISEMENT

Pfizer kicks $25M into CellCentric 

Crossbow Therapeutics launches with $80M to target cancer

Immune memory research could lead to next generation of epigenetic drugs

Existing cancer drug could be repurposed to fight certain aggressive cancers

In Depth 10 Jul 2023

“Ready-to-use” enzymatically produced cell-free synthetic DNA in mRNA manufacturing

In Depth 10 Jul 2023

Making an impact through targeting mRNA

ADVERTISEMENT